Edition:
India

People: Evolus Inc (EOLS.OQ)

EOLS.OQ on NASDAQ Stock Exchange Global Market

10.23USD
21 Feb 2020
Change (% chg)

$-0.24 (-2.29%)
Prev Close
$10.47
Open
$10.43
Day's High
$10.45
Day's Low
$9.98
Volume
127,800
Avg. Vol
163,398
52-wk High
$29.50
52-wk Low
$9.20

Moatazedi, David 

Mr. David Moatazedi is President, Chief Executive Officer, Director of the Company. He was the Senior Vice President at Allergan, Inc. (“Allergan”), and division head of the U.S. Medical Aesthetics division, which includes facial aesthetics, plastic surgery, regenerative medicine, body contouring, and skin care products from March 2016 to May 2018. Since March 2017, Mr. Moatazedi has served as a member of the board of directors of Obalon Therapeutics, Inc., a public medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Mr. Moatazedi has worked in various leadership capacities within Allergan since March 2005, including as Vice President, Sales and Marketing of the U.S. Facial Aesthetics division from August 2014 to March 2016 and Vice President, Sales and Market of the U.S. Plastic Surgery division from February 2013 to August 2014. Prior to Allergan, Mr. Moatazedi was a district manager at Novartis Pharmaceuticals for the Dermatology division. Mr. Moatazedi holds an M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach.

Basic Compensation

Total Annual Compensation, USD 798,375
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 4,995,800
Fiscal Year Total, USD 5,794,180

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Vikram Malik

158,901

David Moatazedi

5,794,180

Lauren Silvernail

3,656,890

Michael Jafar

3,929,160

Alejandro Sabad

--

Kurt Knab

--
As Of  31 Dec 2018